ArticleFish physiology and biochemistry2025
Dose-dependent benefits of dietary yeast cell wall supplementation on the growth performance and stress resilience of the European seabass (Dicentrarchus labrax).
Article in Fish physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Yeast-Derived Postbiotics for Prevention of Enteric Diseases in Farm Animals: Current Insights and Future Perspectives.Veterinary sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preventive health management is central to modern aquaculture practices, within which functional feed additives are a key tool to optimising fish robustness and disease resilience. Despite being well documented, only few studies have assessed the dose-effect of graded levels of S. cerevisiae yeast cell wall (YCW) on fish performance and mucosal barrier immunity. A 9-week trial was conducted to assess the impact of graded levels of YCW on the performance and mucosal barriers of the European seabass under period: (1) non-challenge (43 days) then (2) with an applied husbandry stressors (20 days) in the form of high stocking density, low water oxygen level, and repetitive handling. The four experimental diets were produced by incorporating graded levels of YCW (0.0, control; 1.5; 3.0 or 4.5 kg/MT) which were top dressed on the basal diet prior extrusion. At the end of the period 1, fish supplemented with YCW at 4.5 kg/MT revealed a 5% increase in body-weight compared to the control. Likewise, throughout the experimental period SGR and FCR were also improved by YCW supplementation (+ 5.8% and + 8.3% with YCW4.5, respectively). Supplemented diets increased intraepithelial lymphocytes density and the highest level of intake was associated with increased skin mucus secretion (+ 31% with YCW 4.5 kg/MT). Finally, we observed a linear relationship between fecal calprotectin-like levels and the YCW gradient: a positive correlation during period 1 and a negative correlation during period 2. In contrast, YCW supplementation levels were characterized by a positive linear relationship with fecal mucins across both periods. These results provide novel insights on the benefits and associated mechanisms of YCW extracts and reveal an optimal dose response with inclusion levels between 3.0 and 4.5 kg/MT. This study demonstrates that YCW dietary inclusion enhances growth performance, feed utilization, and mucosal immune barrier function in European seabass, with improved stress resilience evidenced by biomarkers fecal calprotectin-like and fecal mucins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.